About InspireMD, Inc.
https://www.inspiremd.comInspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific.
CEO
Marvin L. Slosman
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2021-04-27 | Reverse | 1:15 |
| 2019-04-01 | Reverse | 1:50 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
ROSALIND ADVISORS, INC.
Shares:3.91M
Value:$6.21M
NANTAHALA CAPITAL MANAGEMENT, LLC
Shares:3.38M
Value:$5.37M
ABRDN PLC
Shares:2.48M
Value:$3.94M
Summary
Showing Top 3 of 43
About InspireMD, Inc.
https://www.inspiremd.comInspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.52M ▲ | $13.91M ▲ | $-12.71M ▲ | -503.69% ▲ | $-0.17 ▲ | $-12.6M ▲ |
| Q2-2025 | $1.78M ▲ | $13.33M ▲ | $-13.15M ▼ | -739.65% ▼ | $-0.26 ▼ | $-12.91M ▼ |
| Q1-2025 | $1.53M ▼ | $11.75M ▲ | $-11.17M ▼ | -730.28% ▼ | $-0.22 ▼ | $-11.36M ▼ |
| Q4-2024 | $1.95M ▲ | $9.84M ▲ | $-9.17M ▼ | -470.7% ▼ | $-0.19 ▼ | $-9.29M ▼ |
| Q3-2024 | $1.81M | $8.88M | $-7.89M | -435.91% | $-0.16 | $-8.39M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $63.4M ▲ | $78.47M ▲ | $14.36M ▲ | $64.11M ▲ |
| Q2-2025 | $19.37M ▼ | $33.34M ▼ | $13.1M ▲ | $20.24M ▼ |
| Q1-2025 | $26.09M ▼ | $38.67M ▼ | $10.33M ▼ | $28.34M ▼ |
| Q4-2024 | $34.64M ▼ | $46.81M ▼ | $10.72M ▲ | $36.09M ▼ |
| Q3-2024 | $40.4M | $50.48M | $9.13M | $41.35M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-12.71M ▲ | $-8.63M ▼ | $7.55M ▲ | $52.93M ▲ | $51.89M ▲ | $-8.96M ▼ |
| Q2-2025 | $-13.15M ▼ | $-8.33M ▲ | $5.32M ▲ | $2.14M ▲ | $-874K ▲ | $-8.91M ▲ |
| Q1-2025 | $-11.17M ▼ | $-8.79M ▼ | $1.7M ▼ | $506K ▼ | $-6.53M ▼ | $-9.15M ▼ |
| Q4-2024 | $-9.17M ▼ | $-6.75M ▼ | $8.24M ▲ | $1.56M ▲ | $3.1M ▲ | $-7.06M ▼ |
| Q3-2024 | $-7.89M | $-5.7M | $-5.92M | $-965K | $-12.57M | $-6.12M |
Revenue by Products
| Product | Q3-2022 | Q1-2023 | Q2-2023 | Q3-2023 |
|---|---|---|---|---|
 CGuard EPS | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 CGuard | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q3-2025 | Q2-2025 |
|---|---|---|---|---|
 GERMANY | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 ITALY | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Other Countries | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 POLAND | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 UNITED STATES | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Marvin L. Slosman
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2021-04-27 | Reverse | 1:15 |
| 2019-04-01 | Reverse | 1:50 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
ROSALIND ADVISORS, INC.
Shares:3.91M
Value:$6.21M
NANTAHALA CAPITAL MANAGEMENT, LLC
Shares:3.38M
Value:$5.37M
ABRDN PLC
Shares:2.48M
Value:$3.94M
Summary
Showing Top 3 of 43